There is also an extensive literature demonstrating the predictive utility of standard Alzheimer’s disease biomarkers (e.g. amyloid-β42, tau, neurofilament light chain) among CN older adults for progression to MCI or Alzheimer’s disease.83–88. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.